TY - JOUR
T1 - Why do young women smoke? VII COMT as a risk modifying gene for Nicotine dependence - Role of gene-gene interaction, personality, and environmental factors
AU - Greenbaum, Lior
AU - Kanyas, Kyra Sarner
AU - Rigbi, Amihai
AU - Alkelai, Anna
AU - Kohn, Yoav
AU - Lerer, Bernard
PY - 2010/11
Y1 - 2010/11
N2 - Objectives Catechol-O-methyltransferase (COMT) may be a risk modifying gene for Nicotine dependence (ND) rather than a direct susceptibility gene for this phenotype. Brain nicotinic cholinergic receptors modulate dopaminergic transmission, and several variants within the neighboring CHRNA5-CHRNA3 genes have been associated with ND. Therefore, it is biologically reasonable to study the interactive contribution of COMT and the CHRNA5 and CHRNA3 genes to ND. Methods Using a case-control sample of 90 young, Israeli, Jewish female smokers (FTND > 4) and 108 controls (FTND = 0 during heaviest period of smoking), we studied association with ND of 8 COMT tagging SNPs, their interaction with tagging CHRNA5-A3 SNPs and the role of background, personality, and environmental factors. Results None of the COMT SNPs were associated directly with ND. In pairwise interaction analysis of SNPs from the two loci (COMT SNP-CHRNA5-CHRNA3 SNP), the interaction of intronic COMT SNP, rs9332377, with CHRNA3 3′UTR SNP rs660652 was significantly associated with ND (p = 0.0005), withstanding correction for multiple testing. Conclusion Addition of the genetic interaction variable into a model of non-genetic ND predictors [parental smoking, novelty seeking (NS), and lifetime history of trauma], substantially increases the percentage of ND variance explained by the model, as well as the percentage of cases correctly identified by it.
AB - Objectives Catechol-O-methyltransferase (COMT) may be a risk modifying gene for Nicotine dependence (ND) rather than a direct susceptibility gene for this phenotype. Brain nicotinic cholinergic receptors modulate dopaminergic transmission, and several variants within the neighboring CHRNA5-CHRNA3 genes have been associated with ND. Therefore, it is biologically reasonable to study the interactive contribution of COMT and the CHRNA5 and CHRNA3 genes to ND. Methods Using a case-control sample of 90 young, Israeli, Jewish female smokers (FTND > 4) and 108 controls (FTND = 0 during heaviest period of smoking), we studied association with ND of 8 COMT tagging SNPs, their interaction with tagging CHRNA5-A3 SNPs and the role of background, personality, and environmental factors. Results None of the COMT SNPs were associated directly with ND. In pairwise interaction analysis of SNPs from the two loci (COMT SNP-CHRNA5-CHRNA3 SNP), the interaction of intronic COMT SNP, rs9332377, with CHRNA3 3′UTR SNP rs660652 was significantly associated with ND (p = 0.0005), withstanding correction for multiple testing. Conclusion Addition of the genetic interaction variable into a model of non-genetic ND predictors [parental smoking, novelty seeking (NS), and lifetime history of trauma], substantially increases the percentage of ND variance explained by the model, as well as the percentage of cases correctly identified by it.
KW - CHRNA3
KW - COMT
KW - genetics
KW - interaction
KW - nicotine dependence
UR - http://www.scopus.com/inward/record.url?scp=79951733308&partnerID=8YFLogxK
U2 - 10.1002/hup.1149
DO - 10.1002/hup.1149
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 21312287
AN - SCOPUS:79951733308
SN - 0885-6222
VL - 25
SP - 536
EP - 542
JO - Human Psychopharmacology
JF - Human Psychopharmacology
IS - 7-8
ER -